IDYA
IDEAYA Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$33.81
+2.92%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 37.10x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.72x
- Price / sales
- 13.93x
- Price / cash flow
- -29.22x
Enterprise value
- Enterprise value
- $2.5B
- EV / sales
- 10.52x
- EV / EBITDA
- -13.56x
- EV / EBIT
- -11.35x
- Market cap
- $3.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026